Individuals are incentivized by Data Consumers to share data across the OHX. Through OHX they are able to directly share data with anyone they choose, and control access to their own critical data. Individuals are not required to share data, and can choose to opt-in or opt-out of the Smart Exchange at any time.
Healthcare providers can use the AI built into the system to identify individuals in their patient population who are sick and may not even be aware of it. This would allow for OHX to enable the healthcare system to identify Individuals with certain diseases based on biomarker data. If we flag an individual to be of concern, a healthcare system or Accountable Care Organization (ACO), would be immediately notified, and could request Individual to come in for treatment via Individual request portal. Once the patient comes in they are treated proactively within the system, to support preventive measures.
Clinical research studies today conducted independently or sponsored by pharmaceutical or biotechnology companies have many restrictions. For many patients, data is not immediately available and/or has to be pre-identified. For example, in a clinical trial focused on thyroid conditions, researchers may have determined there are only a certain type of tests they would want to measure for as they are directly relevant to the results of the study. Adding additional tests may not prove valuable and could be adding unnecessary cost.
PhD, EE, Cambridge University Technologist & Serial Entrepreneur Inventor core technology for Orphidia multi-biomarker microfluidic technology
PhD, Computer Science, TU Berlin. Python C C++ Java JSON R Hadoop. Professor at SRH University, Berlin. International Leader in Cybersecurity. 90 publications in Information Systems
PharmD, MS. Led 3 pharma/medtech launches >$100M+. Led product management for health system analytics. Serial entrepreneur, founder of PillTalk
PhD, Biotechnology, Cambridge University. Founder & Managing Director, Camtech. Aktivo Labs, JN Medsys, & Bandlab Technologies
Serves to ensure trust management across the ecosystem with where individuals can authorize various data consumers access to data through smart contracts
Massive amounts of high quality data are needed to drive forward AI/ML, — OHX will allow data to power new AI discoveries and analyses for decision making
Privacy and security are the utmost priority as they will be critical to achieve mainstream adoption. HIPAA and EU-GDPR data protection standards will be rigorously maintained.